Abstract | BACKGROUND: METHODS: Fifty-five patients with portal hypertension were included in this retrospective study. Among them, 27 patients underwent EDWS, and the other 28 patients underwent MED. Patients' characteristics, perioperative parameters and long-term follow-up were analyzed. RESULTS: The portal venous pressure was decreased by 20% postoperatively in both groups. The morbidity rate of portal venous system thrombosis in the EDWS group was significantly lower than that in the MED group (P=0.032). The 1- and 3-year recurrence rates of esophagogastric variceal hemorrhage were 0% and 4.5% in the EDWS group, and 0% and 8.7% in the MED group, respectively (P=0.631). CONCLUSIONS: EDWS is a safe and effective treatment for esophagogastric varices secondary to portal hypertension in selected patients. Patients treated with EDWS had a lower complication rate of portal venous system thrombosis compared with those treated with conventional MED.
|
Authors | Yan-Bin Ni, Peng-Ji Gao, Dong Wang, Zhao Li, Ji-Ye Zhu |
Journal | Hepatobiliary & pancreatic diseases international : HBPD INT
(Hepatobiliary Pancreat Dis Int)
Vol. 14
Issue 3
Pg. 276-80
(Jun 2015)
ISSN: 1499-3872 [Print] Singapore |
PMID | 26063028
(Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't)
|
Topics |
- Adult
- Disease-Free Survival
- Esophageal and Gastric Varices
(diagnosis, etiology, surgery)
- Female
- Gastrointestinal Hemorrhage
(diagnosis, etiology, surgery)
- Hemostatic Techniques
(adverse effects)
- Humans
- Hypertension, Portal
(complications, diagnosis, physiopathology, surgery)
- Male
- Middle Aged
- Recurrence
- Retrospective Studies
- Splenectomy
(adverse effects)
- Time Factors
- Treatment Outcome
- Vascular Surgical Procedures
(adverse effects)
- Venous Pressure
- Venous Thrombosis
(etiology)
|